Purpose: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. Materials and methods: Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. Results: From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52-90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (...
Purpose:To assess the impact of fractionation upon tumor control and toxicity in medically inoperabl...
PURPOSE: To examine potential dose-response relationships with various non-small-cell lung cancer (N...
PurposeTo compare 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable ea...
Background: To clarify the clinical outcomes of two dose schedule of stereotactic body radiotherapy ...
Abstract Purpose To investigat...
PURPOSE: The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of ...
Purpose: To report the clinical outcome of treatment using real-time tumor tracking for 70 patients ...
Purpose: To report the clinical outcome of treatment using real-time tumor tracking for 70 patients ...
BACKGROUND: Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonopera...
BACKGROUND: Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonopera...
BACKGROUND: Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonopera...
Background: The purpose of this study was to evaluate treatment patterns and outcomes of stereotacti...
Purpose: Stereotactic radiotherapy (SRT) has been increasingly performed to treat peripheral Stage I...
Objective: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for m...
Stereotactic body radiotherapy (SBRT) uses hypofractionated and more precise irradiation methods, an...
Purpose:To assess the impact of fractionation upon tumor control and toxicity in medically inoperabl...
PURPOSE: To examine potential dose-response relationships with various non-small-cell lung cancer (N...
PurposeTo compare 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable ea...
Background: To clarify the clinical outcomes of two dose schedule of stereotactic body radiotherapy ...
Abstract Purpose To investigat...
PURPOSE: The impact of stereotactic body radiotherapy (SBRT) on 3-year progression-free survival of ...
Purpose: To report the clinical outcome of treatment using real-time tumor tracking for 70 patients ...
Purpose: To report the clinical outcome of treatment using real-time tumor tracking for 70 patients ...
BACKGROUND: Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonopera...
BACKGROUND: Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonopera...
BACKGROUND: Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonopera...
Background: The purpose of this study was to evaluate treatment patterns and outcomes of stereotacti...
Purpose: Stereotactic radiotherapy (SRT) has been increasingly performed to treat peripheral Stage I...
Objective: To examine disease control and survival after stereotactic body radiotherapy (SBRT) for m...
Stereotactic body radiotherapy (SBRT) uses hypofractionated and more precise irradiation methods, an...
Purpose:To assess the impact of fractionation upon tumor control and toxicity in medically inoperabl...
PURPOSE: To examine potential dose-response relationships with various non-small-cell lung cancer (N...
PurposeTo compare 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable ea...